[1]
P. Pozo Sanhueza, J. P. Mondaca Muñoz, P. A. Diaz Aguirre, and J. C. Escalona Arranz, “Applications and limitations of CRISPR-Cas9 in breast cancer therapy: A structured evidence review (2018–2026)”, Orange. J., vol. 8, no. 14, pp. 36–51, Oct. 2026.